Crossmark

Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

Crossref DOI link: https://doi.org/10.1007/s00198-023-06887-4

Published Online: 2023-08-18

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Everts-Graber, Judith https://orcid.org/0000-0002-8792-8199
Bonel, Harald

Lehmann, Daniel

Gahl, Brigitta https://orcid.org/0000-0001-8123-0438
Häuselmann, HansJörg

Studer, Ueli

Ziswiler, Hans-Rudolf

Reichenbach, Stephan https://orcid.org/0000-0001-8098-6567
Lehmann, Thomas https://orcid.org/0000-0003-0739-5562
License Information

Text and Data Mining valid from 2023-08-18

Version of Record valid from 2023-08-18
More Information

Article History

First Online: 18 August 2023